Opus Genetics, Inc. (IRD)
5.23
+0.02
(+0.38%)
USD |
NASDAQ |
Apr 24, 16:00
5.215
-0.02
(-0.29%)
After-Hours: 20:00
Opus Genetics EPS Diluted (Quarterly) : -0.2364 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | -0.8626 |
| Moderna, Inc. | -2.107 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.52M |
| Revenue (Quarterly) | 3.865M |
| Total Expenses (Quarterly) | 20.39M |
| Enterprise Value | 328.15M |
| Gross Profit Margin (Quarterly) | 99.66% |
| Profit Margin (Quarterly) | -427.5% |
| Earnings Yield | -16.11% |
| Normalized Earnings Yield | -14.51 |